← Back to all trials
Not Yet Recruiting
NCT05611346
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
Conditions: Dermatitis
Sex: All
Ages: 8 Years – 17 Years
Phase: NA
Enrollment: 32
Sponsor: Centre Hospitalier Universitaire de la Réunion
Location: Réunion
Summary
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children.
It causes pruritus and skin lesions that can have a significant impact on patients' quality of life.
AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products.
Patients are often looking for therapeutic alternatives.
Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement.
Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD.
These results are encouraging but limited by the absence of a control group or by the small population included.
Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
Eligibility Criteria
Inclusion Criteria:Children aged 8 to 17 yearsUnderstanding frenchWith moderate to severe AD clinically diagnosed by a physician (SCORing Atopic Dermatitis (SCORAD) ≥ 25)Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion University Hospital.
- Oral consent of the child and of one of the legal representatives collected.Exclusion Criteria:Children refusing to participate in the hypnosis sessionNot having the possibility to listen to an audio file,Already practicing self-hypnosis for their AD before inclusion,Having a contraindication to hypnosis (psychiatric disorders, psychosis)Treated by a systemic treatment for their AD.
Source: ClinicalTrials.gov (NCT05611346). StuddyBuddy aggregates publicly available trial information.